Patents by Inventor Way-Yu Lin

Way-Yu Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC USES OF BERBERINE FORMULATIONS
    Publication number: 20170354649
    Abstract: Uses of pharmaceutical compositions comprising berberine for treatment of dermatologic toxicities and other skin disorders.
    Type: Application
    Filed: August 21, 2017
    Publication date: December 14, 2017
    Inventors: Pao-Li Wang, Way-Yu Lin, Chen-Mao Lin, Po-Yuan Tseng
  • THERAPEUTIC USES OF BERBERINE FORMULATIONS
    Publication number: 20160263092
    Abstract: Uses of pharmaceutical compositions comprising berberine for treatment of dermatologic toxicities and other skin disorders.
    Type: Application
    Filed: May 23, 2016
    Publication date: September 15, 2016
    Inventors: Pao-Li Wang, Way-Yu Lin, Chen-Mao Lin, Po-Yuan Tseng
  • Berberine formulations and uses thereof
    Patent number: 9427432
    Abstract: Pharmaceutical compositions comprising berberine for treatment of skin disorders and methods of use thereof.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: August 30, 2016
    Assignee: TWi Biotechnology, Inc.
    Inventors: Pao-Li Wang, Way-Yu Lin, Chen-Mao Lin, Po-Yuan Tseng
  • BERBERINE FORMULATIONS AND USES THEREOF
    Publication number: 20150174109
    Abstract: Pharmaceutical compositions comprising berberine for treatment of skin disorders and methods of use thereof.
    Type: Application
    Filed: December 19, 2014
    Publication date: June 25, 2015
    Inventors: Pao-Li Wang, Way-Yu Lin, Chen-Mao Lin, Po-Yuan Tseng
  • PHARMACEUTICAL COMPOSITION WITH ENHANCED SOLUBILITY CHARACTERISTICS
    Publication number: 20120022149
    Abstract: There are disclosed pharmaceutical compositions, particularly ophthalmic compositions, that contain relatively high concentrations of solubility enhancing polymer (e.g., polyether polymer, polyvinyl polymer or a combination thereof) for providing enhanced solubility of one or more therapeutic agents. In a preferred embodiment, the composition is a multi-dose topical aqueous ophthalmic composition that contains relatively high concentrations of solubility enhancing polymer (e.g., polyether polymer, polyvinyl polymer or a combination thereof) for providing enhanced solubility of one or more therapeutic agents.
    Type: Application
    Filed: July 20, 2011
    Publication date: January 26, 2012
    Inventors: Masood A. Chowhan, Malay Ghosh, Wesley Wehsin Han, Way-Yu Lin, Vincent Nguyen
  • PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
    Publication number: 20070149593
    Abstract: The present invention relates to development of efficacious intravitreal pharmaceutical compositions comprising a poorly water soluble agent with anti-angiogenic and/or anti vascular leakage properties in a therapeutically effective amount and a co-solvent in a suitable amount to treat or prevent diseases due to ocular neovascularization and enhanced vascular permeability. Other aspects of the invention details the development of efficacious compositions for the treatment of the said diseases via periocular, topical and oral administration.
    Type: Application
    Filed: December 19, 2006
    Publication date: June 28, 2007
    Applicant: Alcon, Inc.
    Inventors: Malay Ghosh, Wesley Han, Way-Yu Lin, David Bingaman, Stella Robertson
  • PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
    Publication number: 20070149480
    Abstract: The present invention relates to development of efficacious pharmaceutical compositions comprising an anti-angiogenic compound in a therapeutically effective amount complexed with or encapsulated in a cyclodextrin derivative.
    Type: Application
    Filed: December 21, 2006
    Publication date: June 28, 2007
    Applicant: Alcon, Inc.
    Inventors: Malay Ghosh, Wesley Han, Way-Yu Lin